Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S.

Adagio Medical (Nasdaq:ADGM) announced today that it received FDA investigational device exemption (IDE) to expand its ...

Working with "digital twins" of patients' hearts, doctors improved cardiac ablation outcomes for patients with ...

The Varipulse Pro pulsed field ablation platform, which has received a CE mark, will be a focus at the upcoming European ...

Johnson & Johnson announced launch of VARIPULSE Pro in Europe following CE Mark approval, further advancing its pulsed field ...

Adagio Medical Holdings Inc. (NASDAQ:ADGM) said it has received Investigational Device Exemption (IDE) authorization from the ...

Stereotaxis has launched the Synchrony system for cath laboratories after receiving 510 (k) clearance from the US Food and ...

Researchers found that people with atrial fibrillation had lower MRI-based glymphatic activity and poorer cognitive ...

A local doctor with a heart rhythm problem turns to a colleague for help and a new procedure to treat the issue.

Catheter ablation tools A retrospective study revealed no significant difference in 36-month progression-free survival and renal function outcomes in patients with small renal masses. Microwave ...

Catheter ablation is an important treatment modality for patients with atrial fibrillation (AF). Although the superiority of catheter ablation over antiarrhythmic drug therapy has been demonstrated in ...